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The ATP synthase catalyses the synthesis of ATP from ADP and Pi
using a transmembrane proton motive force generated by the
oxidative respiratory chain. The enzyme can also operate in reverse
as an ATP-dependent proton pump. The ATP synthase from Mycobac-
terium tuberculosis was identiﬁed to be the molecular target of a new
anti-tuberculosis drug, diarylquinoline TMC207 [1]. Detailed func-
tional and structural studies of mycobacterial ATP synthase are
required to understand how the enzyme could be exploited as a drug
target. We are working on the ATP synthase from Mycobacterium
smegmatis. It is a non-pathogenic, fast-growing mycobacterium and
is an ideal model for Mycobacterium tuberculosis. Initial studies
have been focused on the hydrophilic catalytic F1 domain of the M.
smegmatis ATP synthase lacking the delta subunit (MF1). The MF1-
ATPase has been over-expressed in a mycobacterial expression
system. The recombinant MF1-ATPase has been puriﬁed. Like F1-
APTases from some other eubacteria includingM. tuberculosis it has a
latent ATP hydrolysis activity, which is activated by treatment with
trypsin or detergents. Crystals of the puriﬁed enzyme currently
diffract X-rays to 3 Å resolution at a synchrotron source.
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The F1FO ATP synthase catalyzes the synthesis of ATP from ADP and
inorganic phosphate driven by ion (H+ or Na+) motive forces across
the membrane. The hyperthermophilic bacterium A. aeolicus pos-
sesses a nine-subunit F1FO ATP synthase (AAF1FO) . Its genes are split
into four clusters in the genome. AAF1FO differs from the F1FO ATP syn-
thases of non-photosynthetic organisms, because it possesses a hetero-,
not homodimeric peripheral stalk, composed of the b-subunits. Togeth-
er with its high thermal stability, such unique properties make AAF1Fo
an interesting target for studying the mechanisms of energy conserva-
tion at the molecular level. Therefore, to complement the work on the
native AAF1FO, we set out to produce it heterologously in E. coli (EAF1FO).
We could successfully express the subcomplexes FO-b1b2, F1-α3β3γ,
F1-α3β3γε and the entire complex F1FO-α3β3γεab1b2c in E. coli by
using constructs containing native and artiﬁcial operons. After puriﬁ-
cation by afﬁnity chromatography, we characterized the complexes by
blue native PAGE, Western-blots using antibodies speciﬁcally developed
against AAF1FO subunits, size exclusion chromatography, and mass
spectrometry, showing that they correctly contain all respective subunits.
Moreover, we could detect the assembled EAF1FO complexes by single-
particle electron microscopy. Finally, we could show that the EAF1FO
puriﬁed from E. coli possesses a comparable ATP-hydrolysis activity to
AAF1FO, using in-gel activity and phosphate determination assays .
In conclusion, our system allows the generation of AAF1FO in
E. coli, thus offering advantages over the use of costly and not-
manipulatable A. aeolicus cells. The recombinant AAF1FO is amenable
to new experimental approaches, such as site-directed mutagenesis,
in vivo complementation assays, and amino acid labeling. Therefore,
our work provides a valuable genetic platform to study the structure
and function of AAF1FO.
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